If management have such confidence as you believe then they should have something in binding form. If they have a binding verbal or written agreement which gives them such confidence then it is material and they would be obliged to publish it. Conclusion: there is nothing yet material done.
We have a topmanager on board who was priviously topmanager at Gilead. He is supposed to be the driver of future of the company. GOOD! Top science results. And now what?? Business as usual?
The glass is half full.
We know now with high certaincy what board experts elaborated here for a long time: the drug is super and cant be ignored as it "cures" almost without side effects. We know also the future market value which is 20 times higher as it is.
Based on 2 years with this company i believed sp will not get pushed by the conference. As usual, the sp made even a minius.
As further dozens of millions of warrants are waiting for sale at 0.5 and 0.8 and no institutional buyers cant come in, who will be buying all these shares? Either we get a BO/partnership offer or we finally make the R/S or we get a hostile offer or we park the company at this value for another 6 months. Waiting for further much better results, mono, will in this scenario where we are not much of a help.
The window of an incredible opportunity is very wide open. Can management use it?
News 
Market Data 
Discover 
